{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:31:49Z","timestamp":1791210709111,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.1038\/sj.gt.3301602","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:01:47Z","timestamp":1032375707000},"page":"1872-1878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters"],"prefix":"10.1038","volume":"8","author":[{"given":"RD","family":"Weeratna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Efler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HL","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,1,30]]},"reference":[{"key":"BF3301602_CR1","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.160.9.4635","volume":"160","author":"Y Ohtsuka","year":"1998","unstructured":"Ohtsuka Y et al. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy J Immunol 1998 160: 4635\u20134640","journal-title":"J Immunol"},{"key":"BF3301602_CR2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.159.2.685","volume":"159","author":"F van Ginkel","year":"1997","unstructured":"van Ginkel F et al. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene J Immunol 1997 159: 685\u2013693","journal-title":"J Immunol"},{"key":"BF3301602_CR3","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1073\/pnas.95.10.5734","volume":"95","author":"G Evans","year":"1998","unstructured":"Evans G, Morgan R . Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A Proc Natl Acad Sci USA 1998 95: 5734\u20135739","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301602_CR4","first-page":"154","volume":"3","author":"A Kass-Eisler","year":"1996","unstructured":"Kass-Eisler A et al. Circumventing the immune response to adenovirus-mediated gene therapy Gene Therapy 1996 3: 154\u2013162","journal-title":"Gene Therapy"},{"key":"BF3301602_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0014-5793(97)00329-3","volume":"407","author":"K Wells","year":"1997","unstructured":"Wells K et al. Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle FEBS Lett 1997 407: 164\u2013168","journal-title":"FEBS Lett"},{"key":"BF3301602_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1183\/09031936.98.11020492","volume":"11","author":"BJ Petrof","year":"1998","unstructured":"Petrof BJ . Respiratory muscles as a target for adenoviral-mediated gene therapy Eur Respir J 1998 11: 492\u2013497","journal-title":"Eur Respir J"},{"key":"BF3301602_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.184.4.1555","volume":"184","author":"M Corr","year":"1996","unstructured":"Corr M, Lee D, Carson D, Tighe H . Gene vaccination with naked plasmid DNA: mechanism of CTL priming J Exp Med 1996 184: 1555\u20131560","journal-title":"J Exp Med"},{"key":"BF3301602_CR8","doi-asserted-by":"publisher","first-page":"8578","DOI":"10.1073\/pnas.93.16.8578","volume":"93","author":"B Doe","year":"1996","unstructured":"Doe B et al. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells Proc Natl Acad Sci USA 1996 93: 8578\u20138583","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301602_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.159.1.11","volume":"159","author":"A Iwasaki","year":"1997","unstructured":"Iwasaki A et al. The dominant role of bone-marrow derived cells in CTL induction following plasmid DNA immunization at different sites J Immunol 1997 159: 11\u201314","journal-title":"J Immunol"},{"key":"BF3301602_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2567.1996.d01-718.x","volume":"89","author":"JB Ulmer","year":"1996","unstructured":"Ulmer JB et al. Generation of MHC class-I restricted T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells Immunology 1996 89: 59\u201367","journal-title":"Immunology"},{"key":"BF3301602_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/BF03401683","volume":"3","author":"T Fu","year":"1997","unstructured":"Fu T et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes Mol Med 1997 3: 362\u2013371","journal-title":"Mol Med"},{"key":"BF3301602_CR12","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/hmg\/2.11.1847","volume":"2","author":"HL Davis","year":"1993","unstructured":"Davis HL, Michel M-L, Whalen RG . DNA based immunization induces continuous secretion of for hepatitis B surface antigen and high levels of circulating antibody Hum Mol Genet 1993 2: 1847\u20131851","journal-title":"Hum Mol Genet"},{"key":"BF3301602_CR13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/0264-410X(95)00255-Y","volume":"14","author":"HL Davis","year":"1996","unstructured":"Davis HL, Mancini M, Michel M-L, Whalen RG . DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost Vaccine 1996 14: 910\u2013915","journal-title":"Vaccine"},{"key":"BF3301602_CR14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","volume":"160","author":"HL Davis","year":"1998","unstructured":"Davis HL et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 1998 160: 870\u2013876","journal-title":"J Immunol"},{"key":"BF3301602_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.gt.3300380","volume":"4","author":"HL Davis","year":"1997","unstructured":"Davis HL, Brazolot Millan CL, Watkins SC . Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA Gene Therapy 1997 4: 181\u2013188","journal-title":"Gene Therapy"},{"key":"BF3301602_CR16","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1073\/pnas.92.12.5307","volume":"92","author":"ML Michel","year":"1995","unstructured":"Michel ML et al. DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in humans Proc Natl Acad Sci USA 1995 92: 5307\u20135311","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301602_CR17","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.160.12.5707","volume":"160","author":"MA Chattergoon","year":"1998","unstructured":"Chattergoon MA, Robinason TM, Boyer JD, Weiner DB . Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages\/antigen-presenting cells J Immunol 1998 160: 5707\u20135718","journal-title":"J Immunol"},{"key":"BF3301602_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jlb.61.2.125","volume":"61","author":"E Manickan","year":"1997","unstructured":"Manickan E et al. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells J Leuk Biol 1997 61: 125\u2013132","journal-title":"J Leuk Biol"},{"key":"BF3301602_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0167-5699(94)90006-X","volume":"15","author":"R Hohlfeld","year":"1994","unstructured":"Hohlfeld R, Engel AG . The immunobiology of muscle Immunol Today 1994 15: 269\u2013274","journal-title":"Immunol Today"},{"key":"BF3301602_CR20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA et al. Direct gene transfer into mouse muscle in vivo Science 1990 247: 1465\u20131468","journal-title":"Science"},{"key":"BF3301602_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/hmg\/1.6.363","volume":"1","author":"JA Wolff","year":"1992","unstructured":"Wolff JA et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle Hum Mol Genet 1992 1: 363\u2013369","journal-title":"Hum Mol Genet"},{"key":"BF3301602_CR22","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.158.10.4529","volume":"158","author":"C Torres","year":"1997","unstructured":"Torres C, Iwasaki A, Barber B, Robinson H . Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations J Immunol 1997 158: 4529\u20134532","journal-title":"J Immunol"},{"key":"BF3301602_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nm1096-1122","volume":"2","author":"C Condon","year":"1996","unstructured":"Condon C et al. DNA-based immunization by in vivo transfection of dendritic cells Nat Med 1996 2: 1122\u20131128","journal-title":"Nat Med"},{"key":"BF3301602_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/viro.1999.9795","volume":"260","author":"D Loirat","year":"1999","unstructured":"Loirat D et al. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses Virology 1999 260: 74\u201383","journal-title":"Virology"},{"key":"BF3301602_CR25","unstructured":"Loirat D et al. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses"},{"key":"BF3301602_CR26","doi-asserted-by":"publisher","first-page":"12631","DOI":"10.1073\/pnas.95.21.12631","volume":"95","author":"AM Krieg","year":"1998","unstructured":"Krieg AM et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Proc Natl Acad Sci USA 1998 95: 12631\u201312636","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301602_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/hum.1993.4.2-151","volume":"4","author":"HL Davis","year":"1993","unstructured":"Davis HL, Whalen RG, Demeneix BA . Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression Hum Gene Ther 1993 4: 151\u2013159","journal-title":"Hum Gene Ther"},{"key":"BF3301602_CR28","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1073\/pnas.95.26.15553","volume":"95","author":"CL Brazolot Millan","year":"1998","unstructured":"Brazolot Millan CL et al. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice Proc Natl Acad Sci USA 1998 95: 15553\u201315558","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301602_CR29","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","volume":"161","author":"MJ McCluskie","year":"1998","unstructured":"McCluskie MJ, Davis HL . CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice J Immunol 1998 161: 4463\u20134466","journal-title":"J Immunol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301602","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:11:25Z","timestamp":1682356285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2001,12,1]]}},"alternative-id":["BF3301602"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301602","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12,1]]},"assertion":[{"value":"8 March 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}